ArticleBlood2013
Genomic impact of transient low-dose decitabine treatment on primary AML cells.
Jeffery M Klco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
106 papers cite itlatest 60 shown
this paperpooled ittrialcites it